| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |